Katharine Minker

Katharine Minker serves as a procurement specialist focused on advancing scientific and technical research initiatives within the federal government. She manages the acquisition of complex R&D services spanning physical, engineering, and life sciences, ensuring alignment with agency mission objectives and compliance with federal contracting regulations. Her work centers on securing innovative solutions through competitive solicitation processes, including broad agency announcements and small business set-asides, with a strong emphasis on technical merit and scientific rigor. She plays a critical role in translating research priorities into actionable contract vehicles that support national scientific advancement. Her contractor relationships are primarily with mid-to-large-sized research institutions, private R&D firms, and specialized scientific service providers engaged in experimental design, data analysis, and laboratory operations. While no single contractor dominates her portfolio, she consistently engages vendors with proven expertise in laboratory automation, clinical trial support, and computational modeling. Her procurement approach favors performance-based contracting and outcome-driven deliverables, encouraging innovation through clear statement of work development and rigorous technical evaluation criteria. Katharine’s contracting patterns reflect a strong preference for open competition, with 100% of her acquisitions issued without socioeconomic set-asides. This indicates a focus on technical capability over socioeconomic criteria, aligning with mission-critical needs where specialized expertise outweighs small business participation targets. While she does not prioritize 8(a), HUBZone, or SDVOSB programs, her approach remains fully compliant with FAR requirements and emphasizes merit-based selection. Her primary NAICS focus lies in research and development services, with 45.5% of her acquisitions under 541712 (physical and engineering sciences R&D), 36.4% under 541714 (biotechnology R&D), and 18.2% under 541715 (other life sciences R&D). She procures advanced analytical tools, laboratory instrumentation, bioinformatics platforms, and scientific consulting services, demonstrating deep expertise in life sciences, molecular research, and engineering innovation. Her domain knowledge ensures that contract requirements are technically precise and aligned with cutting-edge scientific standards.